160 related articles for article (PubMed ID: 2671181)
21. Immuno-PET for tumor targeting.
Lee FT; Scott AM
J Nucl Med; 2003 Aug; 44(8):1282-3. PubMed ID: 12902419
[No Abstract] [Full Text] [Related]
22. PET imaging for planning cancer therapy.
Eary JF
J Nucl Med; 2001 May; 42(5):770-1. PubMed ID: 11337574
[No Abstract] [Full Text] [Related]
23. Gamma camera emission tomography using radiolabelled antibodies.
Perkins AC; Whalley DR; Ballantyne KC; Pimm MV
Eur J Nucl Med; 1988; 14(1):45-9. PubMed ID: 3260179
[TBL] [Abstract][Full Text] [Related]
24. The utility of monoclonal antibodies in the imaging of prostate cancer.
Yao D; Trabulsi EJ; Kostakoglu L; Vallabhajosula S; Joyce MA; Nanus DM; Milowsky M; Liu H; Goldsmith SJ
Semin Urol Oncol; 2002 Aug; 20(3):211-8. PubMed ID: 12215974
[TBL] [Abstract][Full Text] [Related]
25. Tumor localization using radiolabeled monoclonal antibodies. An overview.
Zalcberg JR
Am J Clin Oncol; 1985 Dec; 8(6):481-9. PubMed ID: 3909809
[TBL] [Abstract][Full Text] [Related]
26. Synergistic value of single-photon emission computed tomography/computed tomography fusion to radioimmunoscintigraphic imaging of prostate cancer.
Sodee DB; Sodee AE; Bakale G
Semin Nucl Med; 2007 Jan; 37(1):17-28. PubMed ID: 17161036
[TBL] [Abstract][Full Text] [Related]
27. BIS-1: a novel bispecific monoclonal antibody for CEA-expressing carcinoma radioimmunoscintigraphy and radioimmunotherapy.
Parisi A; Bartolazzi A; Bonino C; Camagna M; DeMonte LB; Lombardi A; Natali PG; Paganelli G; Tarditi L; Vassarotto C
Year Immunol; 1993; 7():96-105. PubMed ID: 8372516
[No Abstract] [Full Text] [Related]
28. Targeting cancer with radiolabeled antibodies.
Goldenberg DM; Larson SM; Reisfeld RA; Schlom J
Immunol Today; 1995 Jun; 16(6):261-4. PubMed ID: 7662094
[No Abstract] [Full Text] [Related]
29. Intraperitoneal radioimmunotherapy in an ovarian carcinoma mouse model: Effect of the radionuclide.
Janssen ML; Pels W; Massuger LF; Oyen WJ; Boonstra H; Corstens FH; Boerman OC
Int J Gynecol Cancer; 2003; 13(5):607-13. PubMed ID: 14675343
[TBL] [Abstract][Full Text] [Related]
30. Monoclonal antibodies: old and new trends in breast cancer imaging and therapeutic approach.
Stipsanelli E; Valsamaki P
Hell J Nucl Med; 2005; 8(2):103-8. PubMed ID: 16142251
[TBL] [Abstract][Full Text] [Related]
31. [Nuclear medicine in oncology: new diagnostic and therapeutic methods].
Maublant J; Lumbroso J; Cachin F; Raoul JL; Syrota A; Vuillez JP
Bull Cancer; 2001 Jan; 88(1):35-44. PubMed ID: 11182651
[No Abstract] [Full Text] [Related]
32. Imaging and therapy of cancer with radiolabeled monoclonal antibodies.
Goldenberg DM
Prog Clin Biol Res; 1989; 288():413-27. PubMed ID: 2654957
[No Abstract] [Full Text] [Related]
33. High-quality 124I-labelled monoclonal antibodies for use as PET scouting agents prior to 131I-radioimmunotherapy.
Verel I; Visser GW; Vosjan MJ; Finn R; Boellaard R; van Dongen GA
Eur J Nucl Med Mol Imaging; 2004 Dec; 31(12):1645-52. PubMed ID: 15290121
[TBL] [Abstract][Full Text] [Related]
34. Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin.
Koppe MJ; Bleichrodt RP; Soede AC; Verhofstad AA; Goldenberg DM; Oyen WJ; Boerman OC
J Nucl Med; 2004 Jul; 45(7):1224-32. PubMed ID: 15235070
[TBL] [Abstract][Full Text] [Related]
35. Radioimmunotherapy with 90Y-labeled monoclonal antibodies in a nude mouse ovarian cancer model.
Kairemo K; Ljunggren K; Strand SE; Hiltunen J; Penttilä P; Nikula T; Laine A; Wahlström T
Acta Oncol; 1993; 32(7-8):801-5. PubMed ID: 8305229
[TBL] [Abstract][Full Text] [Related]
36. Intraperitoneal immunotherapy of cancer: a review of options for treatment.
van Ravenswaay Claasen HH; Eggermont AM
Cancer Treat Res; 1996; 82():13-40. PubMed ID: 8849941
[No Abstract] [Full Text] [Related]
37. [Immunoscintigraphy and radioimmunotherapy of cancer using monoclonal antibodies].
Oriuchi N
Gan To Kagaku Ryoho; 1999 May; 26(6):762-7. PubMed ID: 10410144
[TBL] [Abstract][Full Text] [Related]
38. Aiming for a direct hit: combining molecular imaging with targeted cancer therapy.
Reilly RM
J Nucl Med; 2009 Jul; 50(7):1017-9. PubMed ID: 19525475
[No Abstract] [Full Text] [Related]
39. Antibody-based cancer therapies: back to "polyclonals"?
Paganelli G; De Santis R
Eur J Nucl Med Mol Imaging; 2004 Nov; 31(11):1453-5. PubMed ID: 15258701
[No Abstract] [Full Text] [Related]
40. Anti-L1CAM radioimmunotherapy is more effective with the radiolanthanide terbium-161 compared to lutetium-177 in an ovarian cancer model.
Grünberg J; Lindenblatt D; Dorrer H; Cohrs S; Zhernosekov K; Köster U; Türler A; Fischer E; Schibli R
Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1907-15. PubMed ID: 24859811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
